• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Information regarding illness cases at SSAB construction site in Luleå

SSAB BPress release08.04.2026, 16.00
Discuss

In connection with groundworks at the construction site of SSAB's new steel mill in Luleå, a total of approximately 20 individuals employed by subcontractors have reported illness-like symptoms. A subset of these has sought medical attention. SSAB has initiated an extended measurement program to identify the root cause of the symptoms. All work at the construction site is paused as a safety measure. Steel production at the Luleå site is proceeding as normal.

A safe work environment is the highest priority for SSAB. SSAB has expanded its program for sampling and measurements in air, soil and equipment/ machinery. This includes an increased number of measurement points as well as additional resources to allow testing for and analysis of additional substances, with the aim of clarifying the cause of the reported symptoms. No deviating values have been detected.

SSAB continuously measures emissions from its existing operations in Luleå, and these remain on normal levels. In connection to the submission of the environmental permit application in 2022, more than 2,000 samples were analyzed at the construction site of the new steel mill.

The only measurements so far that have shown elevated levels (i.e., levels exceeding the Swedish Work Environment Authority's limit values) were recorded on April 2 inside a cab of a tractor doing excavation work where elevated values of nitrogen dioxide and sulphur dioxide were recorded. During these measurements, operators used fan-assisted respiratory protective equipment.

The Swedish Work Environment Agency and the Police have initiated investigations related to worker's safety at the construction site. SSAB will fully collaborate with all governmental investigations.

The cause(s) of the reported symptoms has not yet been identified. Some measurements provide immediate results, while others require further analysis. SSAB will communicate verified information on an ongoing basis as it becomes available on www.ssab.com.

To date, the incidents and the related stoppage have not had any material impact on the timeline or budget of the construction of the Luleå mini-mill or on the operational or financial performance of SSAB.

For further information, please contact:
Helena Norrman, EVP and Head of Group Communications, helena.norrman @ ssab.com,
phone: +46 730 66 53 46
Charlotte Lindevall, Head of External Communications, charlotte.lindevall @ ssab.com, phone: +46 703 44 59 73